The project seeks to develop standardized guidelines and tools to map terms across ontologies and help simplify data search and integration.
The method uses a probabilistic approach to mine drug structure, side effects, and genomic and clinical data to identify new drug targets and mechanisms of action.
With funding from CurePSP, the collaborators will investigate the genetic causes of the disease, which affects a patients' speech, mobility, balance, and other abilities.
Besides optimizing open-source code, the company has forged focused partnerships with multiple bioinformatics firms including Edico Genome and Curoverse.
Under the terms of the agreement, SolveBio will distribute OncoMD, MedGenome's cancer mutation knowledgebase.
In Science this week: factors influencing retrotransposon integration sites, and more.
A bioethicist argues for the responsible use of germline gene editing.
Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.
Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.
This online seminar will demonstrate how RNA-seq analysis in a model organism can provide insights into human disease.